Evogene, Systasy and LMU University Hospital Munich team up on AI-driven drug discovery …

By
DrWeb
-
0
34

Evogene (Nasdaq: EVGN), Systasy Bioscience, and LMU University Hospital Munich announced the partnership on Feb. … generative AI in pharma, IBD, …

Discover more from DrWeb's Domain

Subscribe to get the latest posts sent to your email.

Tags:
No tags for this post.

Leave Your Comments

This site uses Akismet to reduce spam. Learn how your comment data is processed.